Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study.
Joniau S, Briganti A, Gontero P, Gandaglia G, Tosco L, Fieuws S, Tombal B, Marchioro G, Walz J, Kneitz B, Bader P, Frohneberg D, Tizzani A, Graefen M, van Cangh P, Karnes RJ, Montorsi F, Van Poppel H, Spahn M; European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT). Joniau S, et al. Among authors: tizzani a. Eur Urol. 2015 Jan;67(1):157-164. doi: 10.1016/j.eururo.2014.01.020. Epub 2014 Jan 25. Eur Urol. 2015. PMID: 24486307
Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients.
Spahn M, Joniau S, Gontero P, Fieuws S, Marchioro G, Tombal B, Kneitz B, Hsu CY, Van Der Eeckt K, Bader P, Frohneberg D, Tizzani A, Van Poppel H. Spahn M, et al. Among authors: tizzani a. Eur Urol. 2010 Jul;58(1):1-7; discussion 10-1. doi: 10.1016/j.eururo.2010.03.001. Epub 2010 Mar 17. Eur Urol. 2010. PMID: 20299147
Is there a prostate-specific antigen upper limit for radical prostatectomy?
Gontero P, Spahn M, Tombal B, Bader P, Hsu CY, Marchioro G, Frea B, Van Der Eeckt K, Kneitz B, Frohneberg D, Tizzani A, Van Poppel H, Joniau S. Gontero P, et al. Among authors: tizzani a. BJU Int. 2011 Oct;108(7):1093-100. doi: 10.1111/j.1464-410X.2011.10076.x. Epub 2011 Mar 10. BJU Int. 2011. PMID: 21392220
Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer.
Briganti A, Joniau S, Gontero P, Abdollah F, Passoni NM, Tombal B, Marchioro G, Kneitz B, Walz J, Frohneberg D, Bangma CH, Graefen M, Tizzani A, Frea B, Karnes RJ, Montorsi F, Van Poppel H, Spahn M. Briganti A, et al. Among authors: tizzani a. Eur Urol. 2012 Mar;61(3):584-92. doi: 10.1016/j.eururo.2011.11.043. Epub 2011 Dec 2. Eur Urol. 2012. PMID: 22153925
Pretreatment tables predicting pathologic stage of locally advanced prostate cancer.
Joniau S, Spahn M, Briganti A, Gandaglia G, Tombal B, Tosco L, Marchioro G, Hsu CY, Walz J, Kneitz B, Bader P, Frohneberg D, Tizzani A, Graefen M, van Cangh P, Karnes RJ, Montorsi F, van Poppel H, Gontero P; European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT). Joniau S, et al. Among authors: tizzani a. Eur Urol. 2015 Feb;67(2):319-25. doi: 10.1016/j.eururo.2014.03.013. Epub 2014 Mar 21. Eur Urol. 2015. PMID: 24684960
183 results